An example of drug repurposing: ebastine in combination with docetaxel as a treatment for metastatic castration-resistant prostate cancer-the EXUROC prostate study, a clinical trial protocol.
Saved in:
| Title: | An example of drug repurposing: ebastine in combination with docetaxel as a treatment for metastatic castration-resistant prostate cancer-the EXUROC prostate study, a clinical trial protocol. |
|---|---|
| Authors: | Ørum K; Dept. of Oncology, Rigshospitalet, Blegdamsvej 9, Copenhagen, 2100, Denmark. katrine.oerum@regionh.dk., Stormoen DR; Dept. of Oncology, Rigshospitalet, Blegdamsvej 9, Copenhagen, 2100, Denmark., Lauritsen J; Dept. of Oncology, Rigshospitalet, Blegdamsvej 9, Copenhagen, 2100, Denmark., Rohde M; Danish Cancer Society, Copenhagen, Denmark., Jäättelä M; Danish Cancer Society, Copenhagen, Denmark.; Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Pappot H; Dept. of Oncology, Rigshospitalet, Blegdamsvej 9, Copenhagen, 2100, Denmark.; Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. |
| Source: | BMC urology [BMC Urol] 2025 Jul 04; Vol. 25 (1), pp. 154. Date of Electronic Publication: 2025 Jul 04. |
| Publication Type: | Journal Article; Clinical Trial Protocol |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100968571 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2490 (Electronic) Linking ISSN: 14712490 NLM ISO Abbreviation: BMC Urol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471-2490 |
|---|---|
| DOI: | 10.1186/s12894-025-01837-0 |
